Data in the literature suggests that elevated Lp(a) contributes to coronary anery disease. This case study documents the use of ascorbic acid, amino acids lysine and pro/me, an ayurvedic herb gum guggidn, pure crystaline niadn, aridguargum in. lowering Lp(a). These ïnatural substances were well tolerated arid each lowered Lp(a) significantly. In this study (32 months duration) one of the above mentioned substances aridlor an increase or change in dosage was given approximately every two months to a 62 year old female with extremely elevated familial Lp(a). Blood lijpids were drawn and results ivere recorded before changes were made.

At the end of 32 months Lp(a) was reduced by 81 points or 63%. Significant re gression of coronary artery blockages was documented by a Board Certified Car diolo gist who analyzed two angiograms performed one and half years apart, the latter performed 19 months after the study began. It was also observed that Lp(a) decreased directly in relation to the decrease in LDL. Research with clinical studies is recommended to test the efficacy of the above-mentioned nutritional substances in lowering Lp(a) and in both lessening the risk of coronary artery disease and in regressing already existing disease. This is especially crucial for those families with a strong history of familial coronary artery disease and elevated Lp(a).